Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | AANAT | Q16613 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7617019 | 0.85 | PTGS1 (0.54) | MEN1KMT2ALMNASIRT1MAPT | |
| SCHEMBL7641916 | 0.83 | MEN1 (0.58) | MEN1KMT2ALMNASIRT1PTGS1 | |
| SCHEMBL630447 | 0.80 | MAPT (0.47) | MEN1KMT2ALMNASIRT1MAPT | |
| SCHEMBL7618657 | 0.78 | PDPK1 (0.55) | MEN1KMT2ALMNASIRT1PTGS1 | |
| SCHEMBL7614707 | 0.78 | GFER (0.53) | MEN1KMT2ALMNASIRT1CYP1A2 | |
| SCHEMBL7618887 | 0.77 | MEN1 (0.48) | MEN1KMT2ALMNASIRT1MAPT | |
| SCHEMBL28643186 | 0.76 | MEN1 (0.62) | MEN1KMT2ALMNASIRT1MAPT | |
| SCHEMBL7618839 | 0.76 | MTNR1A (0.54) | MEN1KMT2ALMNASIRT1PTGS1 | |
| SCHEMBL7620295 | 0.76 | MEN1 (0.57) | MEN1KMT2ALMNASIRT1PTGS1 | |
| SCHEMBL7619256 | 0.75 | MEN1 (0.48) | MEN1KMT2ALMNASIRT1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020091090-A1 | Somatostatin antagonists and agonists | COLE BRIDGET M (US) | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091090-A1 | Somatostatin antagonists and agonists | GHSR, GHRHR, SSTR3 | MEN1 882/4885KMT2A 1634/4885LMNA 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.